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ABSTRACT
Objective: To document the incidence and prevalence of HIV infection and TB in patients
attending a rural Kenyan hospital.
Design: A retrospective analysis of newly diagnosed HIV and TB-infected patients, HIV and
TB-related admissions, and results of blood donor screening for HIV from 1993 to 1997.
Setting: PCEA Chogoria Hospital, Eastern Province, Kenya.
Subjects: Patients diagnosed with HIV infection and/or TB; all blood donors.
Intervention: Diagnosis of pulmonary TB by Ziehl-Neelsen staining of sputum smears;
diagnosis of smear negative and extrapulmonary TB based on consistent clinical and
radiological features; HIV- 1 and HIV-2 testing of patients clinically suspected to be infected
and all blood donors.
Main outcome measures: Patients diagnosed with HIV and/or TB from 1993 to 1997; the
number of HIV and TB related admissions and the associated mortality rates.
Results: A rising incidence of newly diagnosed HIV patients is documented, and an
increasing number of TB patients are co-infected with HIV. The number of HIV inpatient
episodes is increasing, against a background of falling inpatient and outpatient episodes.
HIV seroprevalence among blood donors is stable at 3 - 4%. The proportion of TB patients
suffering from extrapulmonary TB is increasing (p=0.011), probably as a result of the
increase in HIV.
Conclusion: The HIV epidemic is having an increasing impact on rural Kenyans’ health,
although background seroprevalence rates are apparently stable. TB patients co-infected
with HIV are placing a growing burden on health care resources. All health care facilities
face a challenge as to how best to use limited resources to combat both these deadly diseases.
INTRODUCTION
The enormous burden of human immunodeficiency
virus (HIV) infection in sub-Saharan Africa has been well
documented(1). Seventy  per cent (22.5 million) of the
world’s infected patients live in this region, the majority of
whom have no hope of benefitting from the highly active
(and highly expensive) antiretroviral therapy (HAART),
which has dramatically reduced hospital admission rates
in developed countries(2). In Africa, the HIV epidemic
not only causes substantial morbidity and mortality for
infected individuals, but also creates major social and
economic problems for the wider community. One concern
is the impact the epidemic is having on local health care
facilities, including hospital bed occupancy rates(3).
Another related area of concern is the effect of HIV
infection on the incidence of tuberculosis (TB). Studies
have shown a clear link between HIV and increased rates
of TB infection, with some also indicating higher relapse
rates in dually infected individuals(4). Many of these
studies have been based on urban populations where the
prevalence of HIV tends to be higher, but it is important to
know what impact the epidemic is having on rural
communities also. The Presbyterian Church of East Africa
(PCEA) Chogoria Hospital is situated on the eastern side
of Mount Kenya, in Eastern Province. The hospital’s
catchment area is approximately 3000 km2, and is mainly
rural in nature. Most of the population live and work
locally, but a substantial minority (predominantly male)
work in Nairobi, returning home at the weekends or less
frequently. The data presented here are reviewed to assess
the impact of the HIV epidemic on the local population,
and the hospital itself, over a five year period. Data
concerning new cases of TB and TB- related admissions
are also examined, to see if there have been changes over
the same period.
MATERIALS AND METHODS
At PCEA Chogoria Hospital, TB is diagnosed and treated
in accordance with Kenya’s National TB and Leprosy Programme,
through which antituberculosis drugs are provided free of charge.
The hospital’s laboratory is equipped to perform microscopy and
Ziehl-Neelsen staining of sputum and other specimens. HIV- 1
and HIV-2 antibody testing is carried out by the Capillus latex
aggregation test kit (Cambridge Diagnostics Ireland, Galway,
Ireland), following pre-test counselling and the verbal consent of
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patients suspected to be infected. Post-test counselling is offered
to those individuals whose results are positive. In addition, since
1995 all TB patients have been counselled and tested for HIV
infection, once verbal consent has been obtained. All blood
donors were routinely tested for HIV during the five years
reviewed here; if consent was withheld, no blood was donated by
that person.
The hospital’s computerised database records the number
of inpatient episodes, each coded by diagnosis. It also records the
outcome for each episode. Separate written registers are kept for
outpatient episodes and newly diagnosed HIV and TB patients,
providing a specific record of these cases. A retrospective review
of all patients either admitted or diagnosed with HIV or TB was
carried out, from 1993 to 1997, by examining the computerised
database and the written registers. The results of all blood donors
tested for HIV over the same period were also reviewed. In view
of the relatively crude nature of the data and a number of
potentially confounding variables, statistical analysis was
performed on only a few of the parameters recorded. Where this
was possible, a simple Chi square test was used.
RESULTS
The number of patients presenting with a new diagnosis
of HIV infection and/or TB, from 1993 to 1997 (Table 1)
has increased from 95 to 315. This is despite a decrease in
the total number of outpatient and medical inpatient
episodes since 1994. An increasing proportion (from
seven per cent in 1995 to 22% in 1997) of newly diagnosed
TB cases (Table 1) are co-infected with HIV. The total
number of new TB patients fluctuated over the five-year
period, but there is a statistically significant increase in the
proportion due to extrapulmonary disease. This rises from
6.4% to 16.7% between 1994 and 1997 (p=0.011). There
was no significant change in the proportion of pulmonary
TB patients with smear negative disease, although specific
data are only available from 1995 to 1997. The
seroprevalence of HIV infection among blood donors
ranged from five to three per cent over the five years, but
overall is fairly constant.
Table 1
Details of patients newly diagnosed with HIV and/or TB from 1993 to 1997
1993 1994 1995 1996 1997
HIV 95 126 222 271 315
PTB1 smear  +ve 160
Not known (all PTB) 108 129 111
PTB smear -ve
[% all PTB] Not known 63 (36.8%) 101 (43.9%) 68 (38%)
Extrapulm TB
[% of all TB] Not known 11 (6.4%) 21 (10.9%) 41 (15.1%) 36 (16.7%)
TB (Total) 145 171 192 271 215
% TB cases
 with HIV Not known Not known 7% 17% 22%
% blood donors
with HIV 4.6% 3% 5% 3.5% 3.2%
Outpatient
episodes 62913 70828 66944 62199 54160
1pulmonary tuberculosis
Table 2
Details of medical inpatient episodes diagnosed as HIV or TB from 1993 - 1997
1993 1994 1995 1996 1997
HIV 39 49 91 107 138
(%)1 (1.2%) (1.2%) (2.2%) (3%) (4%)
HIV mortality (%) 28.2% 18.4% 39.6% 39.3% 42.8%
TB 90 69 41 78 113
(%)1 (2.7%) (1.7%) (1%) (2.2%) (3.3%)
TB mortality (%) 17.8% 1.5%2 39% 28.2% 17.7%
Inpatient episodes 3357 4168 4057 3581 3425
1Percentage of all medical inpatient episodes
2See results section
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The number of HIV inpatient episodes (Table 2)
shows a yearly increase, against an overall background of
decreasing medical unit admissions since 1994. The HIV
mortality rate has been stable at approximately 40% from
1995 to 1997; analysing the figures from 1993 to 1997
fails to detect any statistically significant increase in
mortality (p=0.076). The number of TB inpatient episodes,
and the associated mortality rate, has remained relatively
stable over the study period. The mortality rate for TB
inpatients in 1994 is very low in comparison with other
years. Every effort has been made to ensure the data
reported here are complete, but it may be that some
mortality details are missing from 1994 to account for this
apparent anomaly.
DISCUSSION
These results of this study show that, from 1993 to
1997, a growing number of individuals have been diagnosed
with HIV infection at PCEA Chogoria Hospital. This is
perhaps not surprising, but it assumes more significance
when set against the background of declining outpatient
and inpatient numbers attending the hospital. Also, the
proportion of blood donors testing positive for HIV has
remained relatively constant over the five year period.
This raises the possibility that the HIV epidemic may be
stabilising, at least with respect to the incidence of newly
acquired infection. Further evidence of this has been
recently reported from a survey of antenatal patients
attending clinics in Nairobi(5). If this is indeed the case,
this data would suggest that the increasing number of
patients being diagnosed at Chogoria is because of the
natural progression and presentation of the disease in
individuals infected some years previously. On the other
hand, the seroprevalence figures in blood donors may be
an underestimate of the true prevalence. It is widely
known in the community that blood donated at Chogoria
is tested for HIV, and this may be a deterrent to some who
either know or suspect their HIV status to be positive.
However, an anonymous survey of 243 antenatal patients
carried out at Chogoria in 1996 (unreported) found a
similar seroprevalence of 4.1%, but this may also be a
falsely low figure. HIV infected women suffer from
decreased fertility and increased rates of foetal loss, thus
affecting the number attending antenatal clinics(6,7).
The number of HIV related medical inpatient episodes
has increased year on year, although as only those patients
suspected of HIV infection were tested, the results obtained
are likely to be an underestimate of the true figure. Gilks et
al(3) reported that, in 1992, 39% of acute adult medical
admissions to Kenyatta National Hospital, Nairobi were
HIV positive. They also reported a mortality of 35% in
these HIV infected patients, which is similar to the mortality
of approximately 40% seen at Chogoria from 1995 to 1997.
The figures with respect to TB are difficult to analyse
accurately. Patient consultation and admission rates are
likely to have been affected by a number of potentially
confounding factors, such as the introduction of Directly
Observed Therapy, Short-course (DOTS) in 1993, rising
hospital fees and an increased choice of health care facilities
in the local area. These factors might be expected to have
a greater influence on TB patients who are HIV negative,
particularly if they are relatively well, than sicker HIV
positive patients, although this cannot be substantiated.
However, there does appear to be an increase in the
proportion of newly diagnosed TB patients co-infected
with HIV, although the number of TB cases who either
refused testing or were not tested is unknown. In 1997,
22% of newly diagnosed TB patients were HIV infected;
this is similar to the prevalence of 26.5% recorded at the
Infectious Disease Hospital, Nairobi, 1997(8), but lower
than the 60% in Zambia in 1990(9). There has been a
statistically significant increase (p=0.011) in the number
of patients with extrapulmonary TB, as a proportion of all
TB cases. This may well reflect the rising prevalence of
HIV co-infection in the TB cases, as extrapulmonary
disease is more common in these patients(4). Unfortunately,
it is not possible to say, from these data, exactly how many
of the HIV positive patients infected with TB presented
with extrapulmonary disease. Overall, since 1993 the
percentage of medical inpatient episodes due to TB has not
changed dramatically, and neither has the mortality rate, if
one ignores the suspect figure for 1994. It might have been
expected, given the increasing proportion of TB patients
found to be co-infected with HIV, that the mortality rate of
these cases would be higher and thus affect the overall
figure for TB inpatients. However, our data support the
finding of Brindle et al(10), that the increased mortality in
HIV positive patients co-infected with TB may be due to
pathology other than TB itself. It is not possible to report,
from the Chogoria data, how many of the deaths in TB
patients occurred in those co-infected with HIV.
In conclusion, the consequences of HIV infection are
having a growing impact on this part of rural Kenya. This is
despite an apparently stable background seroprevalence.
Malaria remains the commonest medical inpatient diagnosis
at Chogoria, but the rising number of HIV infected patients
requiring admission is likely to have an increasing and
disproportionately higher impact on the amount of resources
used. There also appears to be an increasing proportion of
TB cases co-infected with HIV. Both these facts have
serious implications not only for the health of the local
population, but also in terms of health care resources. A
united effort between the local community and those
providing health care to the community is vital, if progress
is to be made in addressing these life-threatening challenges.
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